甲状腺乳头状癌淋巴结转移分布图谱:淋巴结究竟在何处
回顾性分析2004至2009年一家三级医院416例甲状腺乳头状癌手术患者,35%初诊时存在临床可见淋巴结转移,其中88%有中央区转移、50%有侧颈转移;淋巴结复发患者中9%出现异位转移(最常见于咽后)。甲状腺外侵犯和肿瘤大于4 cm与宏观淋巴结转移相关,CT有助于复发淋巴结的识别与手术规划。
要点
- 初诊时35%患者为cN+,其中88%有中央区淋巴结病、50%有侧颈淋巴结病。
- 淋巴结复发患者中9%出现异位淋巴结转移,最常见于咽后区域。
- 甲状腺外侵犯在无淋巴结病、有淋巴结病和异位淋巴结病患者中的比例分别为8.9%、33.1%和57.1%(P < 0.0001)。
核心结论
- 本报告为大型系列研究,描述了甲状腺乳头状癌原发肿瘤及相关淋巴结病不仅见于中央区和侧颈,也见于异位位置的特征。
- 作者认为相当比例患者初诊时即有中央区淋巴结病,尤其是年轻患者;甲状腺外侵犯和肿瘤大小与宏观淋巴结病(包括异位淋巴结病)相关。
- 淋巴结复发患者中9%存在异位淋巴结,见于多个位置,最常见于咽后;CT扫描可协助复发淋巴结病的识别和手术规划。
研究设计与样本
- 回顾性病历审查,纳入2004至2009年在一家三级医院接受甲状腺切除术和/或颈淋巴结清扫(再次或初次)的甲状腺乳头状癌患者,共416例。
- 术前CT扫描和超声用于识别宏观、临床可见的淋巴结转移(cN+);记录人口学数据、手术类型、淋巴结病和原发肿瘤信息。
- 证据等级:4。
主要发现
- 416例患者中,35%初诊时存在cN+;这些患者中88%有中央区淋巴结病、50%有侧颈淋巴结病。
- 异位淋巴结转移在初诊时未见,但在淋巴结复发患者中9%出现;异位淋巴结通常见于咽后区域,也见于舌下区、皮下、腋窝和胸壁。
- 甲状腺外侵犯在无淋巴结病患者中为8.9%,在有淋巴结病患者中为33.1%,在异位淋巴结病患者中为57.1%(P < 0.0001)。
- 原发肿瘤大小大于4 cm与淋巴结病相关(P = 0.05)。
关键数值与推荐
- cN+定义为术前CT和超声识别的宏观、临床可见淋巴结转移。
- 异位淋巴结转移定义为位于典型中央区或侧颈淋巴结清扫区域之外的淋巴结病。
- 原发肿瘤大小大于4 cm与淋巴结病相关(P = 0.05);甲状腺外侵犯与淋巴结病及异位淋巴结病相关(P < 0.0001)。
临床怎么用
- 作者认为相当比例患者初诊时存在中央区淋巴结病,尤其是年轻患者。
- 作者认为甲状腺外侵犯和肿瘤大小与宏观淋巴结病(包括异位淋巴结病)相关。
- 作者认为CT扫描可协助复发淋巴结病的识别和手术规划。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize nodal disease of patients presenting with papillary thyroid carcinoma (PTC) STUDY DESIGN: Retrospective chart review. METHODS: PTC patients who underwent thyroidectomy and/or neck dissection (revision/primary) from 2004 to 2009 at a tertiary-care hospital were reviewed. Preoperative computed tomography (CT) scan and ultrasonography were utilized to identify macroscopic, clinically apparent nodal metastasis (cN+). Demographic data, type of surgery, nodal disease, and primary tumor information were recorded. RESULTS: Of 416 patients reviewed, 35% had cN+ on initial presentation (IP); of these, 88% and 50% had central (CND) and lateral nodal disease (LND), respectively. The presence of ectopic nodal (END) metastases (nodal disease outside typical CND or LND locations) was absent on IP but occurred in 9% of patients with nodal recurrence. END was typically found in the retropharyngeal area but also was noted in the sublingual region, subcutaneous location, axilla, and chest wall. Extrathyroidal extension (ETE) was found in 8.9% without nodal disease, 33.1% with nodal disease, and 57.1% with END (P < 0.0001). Primary tumor size greater than 4 cm (P = 0.05) was associated with nodal disease. CONCLUSION: This report represents a large series describing characteristics of the primary PTC tumor and associated nodal disease not only in the central and lateral neck but also in the ectopic locations. Our results suggest that a significant proportion of patients will have nodal disease in the central compartment on IP, especially younger patients. ETE and tumor size are associated with macroscopic nodal disease (including END). Nine percent of the patients with nodal recurrence had ectopic nodes occurring in various locations, most commonly in the retropharynx. CT scan can assist with identification and surgical planning of recurrent nodal disease. LEVEL OF EVIDENCE: 4. Laryngoscope, 127:1959-1964, 2017.
引用
- Goyal N, Pakdaman M, Kamani D, et al. Mapping the distribution of nodal metastases in papillary thyroid carcinoma: Where exactly are the nodes? Laryngoscope. 2017. PMID: 28271511. doi:10.1002/lary.26495
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。